Uzbekistan. Uzfarmsanoat

Uzfarmsanoat State Joint-stock Concern, established in June 1993 based on the Decree of the President of Uzbekistan, is the lead industrial association of pharmaceutical companies. The sector has a large developed research and human capacity, supporting training of required chemists and technologists, biotechnologists, engineers, and pharmacists.

There are 8 research institutions (Tashkent Research Institute of Vaccines and Sera, Uzbek Chemical and Pharmaceutical Research Institute, Institute of Chemistry of Vegetable Substance, Institute of Bioorganic Chemistry, Institute of Chemistry and Physics of Polymers, Botanika R&D Center, Oriental Medicine Research Institute, Vaktsina NPO), with 797 staff, of which 75 are doctors of sciences, 207 are candidates for doctors of sciences.

There is Tashkent Pharmaceutical Institute, which annually trains more than 200 pharmacists and industrial pharmacea experts. There are medical drug and industrial pharmaceutical units at 51 medical colleges, which annually train more than 2000 mid-level health workers.

In the last decade the investments into the pharmaceutical sector exceeded USD 130.0 million, of which USD 68.9 million are foreign direct investments.

Foreign partners account for 69% of the capital of the pharmaceutical companies, and local partners account for 31%.

Domestic production only meets the 100% market demand for liquid drugs and bandaging materials. Demand for pills, injection and infusion solutions, ointments, antibiotics, immunobiological substance are met in the range of 20-60%.

Annual demand of domestic market for medications exceeds USD 420 million, of which national output is more than USD 80 million, while remaining drugs are imported, of which USD 40 million come from CIS countries.

Currently Uzfarmsanoat unites 70 pharmaceutical companies or 60% of all companies in the sector. The concern includes research institutions and associations, manufacturing companies of all ownership forms, including joint ventures with foreign investments, joint-stock companies with majority share of private investments.

Most products (76%) are produced by companies under Uzfarmsanoat SJSC.

The Concern focused on promoting the development of the sector and its modernization, technical and technological upgrading, implementation of innovative and applied products into manufacturing.

The mechanism of cooperation of specialized institutions of the Academy of Sciences and the Ministry of Health with the pharmaceutical companies is being developed. To this end, Uzfarmsanoat SJSC is co-financing innovative projects to set up new technologies for production of medical drugs. Serial production of 35 medical drugs has been organized based on mutual cooperation at the experimental bases of academic and sectoral institutions in the last 3 years.

The companies under the Concern manufacture 18 types and forms of medical drugs and products: vials, pills, capsules, solutions, drops, tinctures, extracts, ointments, liniments, infusion solutions, medical drugs, bacterial and diagnostic preparations, vaccines, sera, bandages, cotton wool, etc.

70 pharmacotherapeutic groups of drugs are being manufactured including cardiovascular drugs, vitamins, biostimulators, analgetics, anesthetics, antibiotics, TB drugs, anticeptics, anti-parasitic drugs, diagnostic preparations, vaccines, sera, bactericides, and other substances.

Domestic research potential is currently focused on R&D into prevention and treatment of socially significant diseases (HIV, diabetes, cancer) and wide range of cardiovascular, gastrointestinal, and other mass demand drugs, e.g. influenza. The companies of different ownership forms manufacturing medical drugs account for more than 35% of the concern. More than 90% of concern’s companies are located in Tashkent city and Tashkent oblast.

Check for all companies within the Uzfarmsanoat holding here

Source: UNDP, Uzfarmsanoat